{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T01:20:51Z","timestamp":1771464051652,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","pregnancyhypertension.org","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/j.preghy.2015.06.001","type":"journal-article","created":{"date-parts":[[2015,6,23]],"date-time":"2015-06-23T05:43:05Z","timestamp":1435038185000},"page":"280-286","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention"],"prefix":"10.1016","volume":"5","author":[{"given":"Gaea S.","family":"Moore","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda A.","family":"Allshouse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia D.","family":"Winn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henry L.","family":"Galan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kent D.","family":"Heyborne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.preghy.2015.06.001_b0005","unstructured":"Dolea C, AbouZahr C. Global burden of hypertensive disorders of pregnancy in the year 2000. Evidence and Information for Policy (EIP), World Health Organization, Geneva, July 2003."},{"key":"10.1016\/j.preghy.2015.06.001_b0010","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/ajh.2008.20","article-title":"Secular trends in the rates of preeclampsia, eclampsia, and gestational hypertension, United States, 1987\u20132004","volume":"21","author":"Wallis","year":"2008","journal-title":"Am J Hypertens"},{"key":"10.1016\/j.preghy.2015.06.001_b0015","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1046\/j.1538-7836.2003.00263.x","article-title":"Placental growth factor and its receptor, vascular endothelial growth factor receptor-1: novel targets for stimulation of ischemic tissue revascularization and inhibition of angiogenic and inflammatory disorders","volume":"1","author":"Autiero","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.preghy.2015.06.001_b0020","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.3109\/14767050902994754","article-title":"A prospective cohort study of the value of maternal plasma concentrations of angiogenic and anti-angiogenic factors in early pregnancy and midtrimester in the identification of patients destined to develop preeclampsia","volume":"22","author":"Kusanovic","year":"2009","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0025","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1080\/14767050701830480","volume":"21","author":"Romero","year":"2008","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0030","first-page":"607","article-title":"Risks for preeclampsia and small for gestational age: predictive values of placental growth factor, soluble fms-like tyrosine kinase-1, and inhibin a in singleton and multiple-gestation pregnancies","volume":"30","author":"Boucoiran","year":"2013","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.preghy.2015.06.001_b0035","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/j.1471-0528.2012.03311.x","article-title":"Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis","volume":"119","author":"Kleinrouweler","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/j.preghy.2015.06.001_b0040","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0045","doi-asserted-by":"crossref","first-page":"995","DOI":"10.3109\/14767058.2013.766694","article-title":"Placental growth factor (PlGF): a key to optimizing fetal growth","volume":"26","author":"Vrachnis","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0050","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/0002-9378(85)90435-1","article-title":"Placental prostacyclin production in normal and toxemic pregnancies","volume":"151","author":"Walsh","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.preghy.2015.06.001_b0055","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(05)71003-5","article-title":"Pre-eclampsia","volume":"365","author":"Sibai","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.preghy.2015.06.001_b0060","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/S0002-9378(85)80221-0","article-title":"Prostacyclin and thromboxane in gynecology and obstetrics","volume":"152","author":"Ylikorkala","year":"1985","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.preghy.2015.06.001_b0065","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.siny.2006.04.001","article-title":"Inflammation and pre-eclampsia","volume":"11","author":"Borzychowski","year":"2006","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0070","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1161\/01.STR.23.10.1400","article-title":"Effects of low-to-high doses of aspirin on platelet aggregability and metabolites of thromboxane A2 and prostacyclin","volume":"23","author":"Tohgi","year":"1992","journal-title":"Stroke"},{"key":"10.1016\/j.preghy.2015.06.001_b0075","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1055\/s-2007-999562","article-title":"Low-dose aspirin: treatment for the imbalance of increased thromboxane and decreased prostacyclin in preeclampsia","volume":"6","author":"Walsh","year":"1989","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.preghy.2015.06.001_b0080","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/AOG.0b013e3181e9322a","article-title":"Prevention of preeclampsia and intrauterine growth restriction with aspirin started in early pregnancy: a meta-analysis","volume":"116","author":"Bujold","year":"2010","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.preghy.2015.06.001_b0085","unstructured":"Perkin-Elmer, Asprin therapy. <http:\/\/www.perkinelmer.com\/pages\/060\/aspirintherapy.xhtml> (accessed 10.28.14)."},{"key":"10.1016\/j.preghy.2015.06.001_b0090","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk. National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0095","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/0002-9378(76)90748-1","article-title":"A standard of fetal growth for the United States of America","volume":"126","author":"Brenner","year":"1976","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.preghy.2015.06.001_b0100","doi-asserted-by":"crossref","first-page":"e13263","DOI":"10.1371\/journal.pone.0013263","article-title":"Soluble fms-Like tyrosine kinase 1 (sFlt1), endoglin and placental growth factor (PlGF) in preeclampsia among high risk pregnancies","volume":"5","author":"Powers","year":"2010","journal-title":"PLoS ONE"},{"key":"10.1016\/j.preghy.2015.06.001_b0105","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1002\/pd.2894","article-title":"Stability of first trimester placental growth factor in serum and whole blood","volume":"31","author":"Cowans","year":"2011","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.preghy.2015.06.001_b0110","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.3109\/14767051003678242","article-title":"Effect of long-term storage on placental growth factor and fms-like tyrosine kinase 1 measurements in samples from pregnant women","volume":"23","author":"Law","year":"2010","journal-title":"J Maternal Fetal Neonatal Med"},{"key":"10.1016\/j.preghy.2015.06.001_b0115","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1182\/blood-2002-11-3423","article-title":"Mechanism of monocyte activation and expression of proinflammatory cytochemokines by placenta growth factor","volume":"102","author":"Selvaraj","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.preghy.2015.06.001_b0120","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4067\/S0034-98872014000300001","article-title":"Et al.","volume":"142","author":"Fuentes","year":"2014","journal-title":"Rev Med Chil"},{"key":"10.1016\/j.preghy.2015.06.001_b0125","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1755-8794-3-22","article-title":"A combined genome-wide linkage and association approach to find susceptibility loci for platelet function phenotypes in European American and African American families with coronary artery disease","volume":"3","author":"Mathias","year":"2010","journal-title":"BMC Med Genomics"},{"key":"10.1016\/j.preghy.2015.06.001_b0130","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2013.03.017","article-title":"Gestational angiogenic biomarker patterns in high risk preeclampsia groups","volume":"209","author":"Maynard","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.preghy.2015.06.001_b0135","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.04.027","article-title":"Preeclampsia in high risk women is characterized by risk group-specific abnormalities in serum biomarkers","volume":"211","author":"Metz","year":"2014","journal-title":"Am J Obstet Gynecol"}],"container-title":["Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778915000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2210778915000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,9]],"date-time":"2024-06-09T17:20:23Z","timestamp":1717953623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2210778915000343"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,10]]},"references-count":27,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2210778915000343"],"URL":"https:\/\/doi.org\/10.1016\/j.preghy.2015.06.001","relation":{},"ISSN":["2210-7789"],"issn-type":[{"value":"2210-7789","type":"print"}],"subject":[],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baseline placental growth factor levels for the prediction of benefit from early aspirin prophylaxis for preeclampsia prevention","name":"articletitle","label":"Article Title"},{"value":"Pregnancy Hypertension: An International Journal of Women's Cardiovascular Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.preghy.2015.06.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 International Society for the Study of Hypertension in Pregnancy. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}